Jump to content

Perfluorocarbon

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by NathanLee (talk | contribs) at 06:02, 23 June 2009 (→‎Eye surgery: - disasterously dooming? how about just disasterous..). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Template:POV-title

Perfluorohexane, a fluorocarbon

Perfluorocarbons (PFCs) are fluorocarbons, compounds derived from hydrocarbons by replacement of hydrogen atoms by fluorine atoms. PFCs are made up of carbon and fluorine atoms only, such as octafluoropropane, perfluorohexane and perfluorodecalin. A perflourocarbon can be arranged in a linear, cyclic, or polycyclic shape.[1]

Perfluorocarbon derivatives are perfluorocarbons with some functional group attached, for example perfluorooctanesulfonic acid. Perfluorocarbon derivatives can be very different from perfluorocarbons in their properties, applications and toxicity.

The term Perfluorinated compounds or perflourochemical (also abbreviated to PFC) may indicate perfluorcarbons, but is often used to include perfluorocarbon derivatives.

Properties

Perfluorocarbons have chemical inertness and thermal stability. This is attributed to the strength of the carbon-fluorine bond and the shielding effect of the fluorine atoms. The electronegativity of fluorine reduces the polarizability of the electron clouds. This results in reduced van der Waals forces between fluorocarbons, as these species tend to be volatile and have low cohesive energies in liquids.[2]

There are five perfluorocarbon gases; tetrafluoromethane (carbon tetrafluoride) (bp −128 °C), hexafluoroethane (bp −78.2 °C), octafluoropropane (perfluoropropane) (bp −36.5 °C), perfluoro-n-butane (bp −2.2 °C) and perfluoro-iso-butane (bp −1 °C). Virtually all the other commercially available perfluorocarbons are liquids (the exception being perfluorocyclohexane, which sublimes at 51 °C.[3]

Perfluorocarbon liquids are colorless. They have high density, up to over twice that of water, due to their high molecular weight. Very low intermolecular forces gives the liquids low viscosities (compared to liquids of similar boiling points), low surface tension and low heats of vaporization. They have particularly low refractive indices too.

They are not miscible with most organic solvents (eg, ethanol, acetone, ethyl acetate and chloroform), but are miscible with some hydrocarbons (eg, hexane in some cases). They have very low solubility in water, and water has a very low solubility in them (on the order of 10 ppm). However, they are relatively good solvents for gases, again because of the very low intermolecular forces.

The number of carbon atoms in the perfluorocarbon molecule largely defines most physical properties. The greater the number of carbon atoms, the higher the boiling point, density, viscosity, surface tension, critical properties, vapour pressure and refractive index. Gas solubility decreases as carbon atoms increase, while melting point is determined by other factors as well, so is not readily predicted.

Manufacture

Prior to World War II, the only known route to perfluorocarbons was by direct reaction of fluorine with the hydrocarbon. This highly exothermic process was capable only of synthesising tetrafluoromethane, hexafluoroethane and octafluoropropane; larger hydrocarbons decomposed in the extreme conditions. The Manhattan project saw the need for some very robust chemicals, including a wider range of perfluorcarbons, requiring new manufacturing methods. The so-called "catalytic" method involved reacting fluorine and hydrocarbon on a bed of gold-plated copper turnings, the metal removing the heat of the reaction (so not really acting as a catalyst at all), allowing larger hydrocarbons to survive the process. However, it was the Fowler process that allowed the large scale manufacture of perfluorcarbons required for the Manhattan project.

The Fowler Process

The Fowler process uses cobalt fluoride to moderate the reaction. In the laboratory, this is typically done in two stages, the first stage being fluorination of cobalt difluoride to cobalt trifluoride.

2 CoF2 + F2 → 2 CoF3

During the second stage, in this instance to make perfluorohexane, the hydrocarbon feed is introduced and is fluorinated by the cobalt trifluoride, which is converted back to cobalt difluoride. Both stages are performed at high temperature.

C6H14 + 28 CoF3 → C6F14 + 14 HF + 28 CoF2

Industrially, both steps are combined, for example in the manufacture of the Flutec range of perfluorocarbons, using a vertical stirred bed reactor, with hydrocarbon introduced at the bottom, and fluorine introduced half way up the reactor. The perfluorocarbon vapor is recovered from the top.

Electrochemical fluorination

An alternative technique, electrochemical fluorination (ECF) (also known as the Simons' process) involves electrolysis of a substrate dissolved in hydrogen fluoride. As fluorine is itself manufactured by the electrolysis of hydrogen fluoride, this is a rather more direct route to perfluorocarbons. The process is run at low voltage (5 - 6 V) so that free fluorine is not liberated. The choice of substrate is restricted as ideally it should be soluble in hydrogen fluoride. Ethers and tertiary amines are typically employed. To make perfluorohexane, trihexylamine is used, for example:

2 N(C6H13)3 + 90 HF → 6 C6F14 + 2 NF3 + 45 H2

The perfluorocarbon amine will also be produced:

N(C6H13)3 + 42 HF → 2 N(C6F13)3 + 21H2

Both of these products, and others, are manufactured by 3M as part of the Fluorinert range.

Medical applications

Medical applications require high purity perfluorocarbons. Impurities with nitrogen bonds can have high toxicity; hydrogen-containing compounds (which can release hydrogen fluoride) and unsaturated compounds must also be excluded. Infrared spectroscopy, nuclear magnetic resonance and cell cultures can be used to test the perfluorocarbon.[4]

Eye surgery

Perfluorocarbons are commonly used in eye surgery as temporary replacements of the vitreous humor in retinal detachment surgery.[citation needed] Retinal tears following a penetrating trauma or retinal detachments associated with proliferative vitreoretinopathy can be corrected with surgery in which the dense perfluorocarbon liquid, typically perfluoro-n-octane, is injected into the eye, to push out vitreous liquid trapped behind the retina, and to aid removal of membranes (essentially scar tissue).[5] Perfluoro-1,3-dimethylcyclohexane has been used in the removal of a lens nucleus dislocated into the vitreous cavity, the lens floating on the heavy perfluorocarbon for easy removal [6].

Octafluoropropane can be used almost in a reverse sense. It is injected into the eye diluted in air (typically 12% to 16%). The patient must then lie face down for about an hour. The gas bubble pushes onto the retina to perform the same task as before [7]. The octafluorpropane may remain in the eye for up to three months after surgery before it is completely expelled. Air travel or other environments involving changes in pressure should be avoided. Use of nitrous oxide as an anaesthetic can be disastrous to the possible future optical abilities of the patient [8]; dissolved nitrous oxide from the blood accumulates in the bubble, increasing intraocular pressure to the point that blood flow to the retina is cut off and the retina dies.

Imaging

Perfluorocarbons are also used in contrast-enhanced ultrasound to improve ultrasound signal backscatter. The perfluorocarbons used in the microbubbles are gases at body temperature (though they may be liquids at room temperature). The gas-filled microbubbles oscillate and vibrate when a sonic energy field is applied and characteristically reflect ultrasound waves. This distinguishes the microbubbles from surrounding tissues. Their stability, inertness, low diffusion rate and solubility increase the duration of contrast enhancement as compared to microbubbles containing air.

Perfluorocarbons can also be used in magnetic resonance imaging (MRI), though this is not as common. Usually MRI is set up to detect hydrogen nuclei, but it is also possible to use MRI for 19-fluorine nuclei. As there is no fluorine in the human body naturally, it is very easy to determine exactly where the sample has gone. Perfluorocarbons can be introduced into the blood in an emulsion, or neat in the lungs.

In radiographic imaging, the perfluorocarbon derivative perfluorooctyl bromide (PFOB) is employed, as this is more opaque to X-rays.

Liquid breathing

Perfluorocarbons dissolve relatively high concentrations of gases, for example, 100 ml of perfluorodecalin at 25°C will dissolve 49 ml of oxygen at STP[9]. This led Leland C. Clark in 1966 to experiment with liquid breathing, resulting in the submersion of a mouse for several hours in an oxygenated perfluorocarbon.[10][11] The mice he used later died due to trauma to their lungs. However, it seems like this was due to impurities in the perfluorocarbon. In recent years there has been new interest in liquid breathing for various procedures from lung lavage to treatment of congenital diaphragmatic hernia. Perfluorocarbon liquids (and liquids in general) are much denser and more viscous than air; rates of breathing, and therefore of gas exchange, are limited, and there are challenges still to be overcome such as efficient removal of carbon dioxide.

Artificial blood

Clark's experiments also triggered interest in using perfluorocarbons in artificial blood (perhaps more accurately described as artificial erythrocytes, as they only serve as gas carriers). The Green Cross Corporation attempted to commercialize this technology in the 1980s under the Fluosol tradename, without success[12]. Recently, however, there has been renewed interest in this field.

In this application, the perfluorocarbon is used as a part of an emulsion, typically using Pluronic F-68 or egg yolk phospholipids (lethicin) as surfactants, in water. For example, Fluosol-DC:[13]

Ingredient w/v%
Perfluorodecalin 25.0
Yolk phospholids 3.6
Fatty acid (emulsion stabilizer) trace
D-Sorbitol (emulsion stabilizer) 3.5
NaCl 0.204
KCl 0.010
MgCl2 0.007
Sodium lactate 0.105

Due to perfluorocarbons size of 0.1 -0.2μm this enables the molecule to be present in the plasma gaps between erythrocytes in the microcirculation structures. These molecules are able to carry 40 to 50 times more oxygen than hemoglobin which is an advantage when oxygen supply to tissue by red blood cells is low due to acute anemia or hemodilution. Perfluorocarbons are most effective in small capillaries or blood vessels, where under normal circumstances blood cells would not be able to flow. PFC's can augment local oxygen delivery and increase the oxygen content in the arterial blood. All oxygen carried by perfluorocarbons is in a dissolved state which results in higher oxygen partial pressures, which in turn augments the driving pressure for the diffusion of dissolved oxygen into the tissue.[14]

Side effects

Some common side effects were recorded while performing clinical studies such as delayed febrile reaction and flu-like symptoms. The magnitude of the side effects is directly related to the size of the emulsion droplets, if the particles are smaller than 0.2μm it seems to be undetectable for the reticuloendothelial system. These side effects occur when the body is excreting/eliminating the perfluorocarbon. The excretion depends on vapour pressure and lipid solubility of the perfluorocarbons. It usually takes on average three to four days for the compound perfluoroocytl bromide and eight days for perfluorodichlorooactane. This process is relatively slow since perfluorocarbons are inert to biochemical degradation. The perfluorocarbon will then diffuse back into the blood where they dissolve into plasma lipids. The plasma lipids will then transport the perfluorocarbon molecules to the lungs where they are excreted through exhalation along with other gases.[15]

Treatment of decompression sickness

Perfluorocarbons accelerate nitrogen washout after venous gas emboli.[16][17] Success in the treatment of decompression sickness has been shown in rat[18], swine[19][20][21], hamster[22] models. This treatment shows great potential as a future adjunctive therapy for decompression sickness in humans.[23]

Non-medical applications

Electrical and electronic applications

Perfluorocarbons have high dielectric strengths and high insulating properties, and so can be used in direct contact with high voltage components, either as dielectric fluids or as coolants[24].

Perfluorcarbon tracers

Perfluorocarbons can be detected at extremely low levels using electron capture detectors or negative ion mass spectroscopy. They can be released at a certain point and the concentration measured in the surrounding area. Perfluorocarbon tracers (PFTs) have been used to map oil fields, study building ventilation, track pollution, detect cable oil leaks and even recover ransom money.

Cosmetics

Inspired by the medical applications, several companies incorporate perfluorocarbons in their cosmetic formulations, claiming the oxygen dissolved in the perfluorocarbon has an anti-aging effect on the skin.[25]

Other applications

PFCs are being used in refrigerating units as replacements for CFCs (haloalkanes), often in conjunction with other gases, and as "clean" fire extinguishers. They are used in plasma cleaning of silicon wafers[26]. Perfluorocarbons are also used in high end racing ski waxes due to their hydrophobic nature, which is responsible for reduced friction in wet snow conditions.

In fluorous biphase catalysis a perfluorocarbon is used to dissolve a catalyst with a perfluoroalkyl group, while the substrate is dissolved in an organic solvent. At elevated temperature, the perfluorocarbon and organic solvent become miscible, and so the mixture becomes homogeneous, facilitating the reaction. Upon cooling, the two phases separate, allowing the catalyst to be recovered from the perfluorocarbon, and the product from the organic solvent.[27]

Environmental effects

PFCs are extremely potent greenhouse gases, and they are a long-term problem with a lifetime up to 50,000 years.[28] In a 2003 study, the most abundant atmospheric PFC was tetrafluoromethane.[28] The greenhouse warming potential (GWP) of tetrafluoromethane is 6,500 times that of carbon dioxide, and the GWP of hexafluoroethane is 9,200 times that of carbon dioxide.[29] Several governments concerned about the properties of PFCs have already tried to implement international agreements to limit their usage before it becomes a global warming issue. PFCs are one of the classes of compounds regulated in the Kyoto Protocol.

The primary source of tetrafluoromethane in the environment is from the production of aluminium by electrolysis of alumina. Aluminium producers are taking effective steps in reducing emissions by better controlling the electrolysis process[30][31].

Two PFC derivatives, perfluorooctanesulfonic acid and perfluorooctanoic acid, have been found to be persistent in the environment and are detected in blood samples all over the world.

See also

References

  1. ^ Perfluorocarbon compounds used as oxygen carriers. https://bdigital.ufp.pt/dspace/bitstream/10284/368/1/perfluorocarbons.pdf
  2. ^ Lemal DM (2004). "Perspective on fluorocarbon chemistry". J. Org. Chem. 69 (1): 1–11. doi:10.1021/jo0302556. PMID 14703372. {{cite journal}}: Unknown parameter |month= ignored (help)
  3. ^ http://www.ornl.gov/~webworks/cpr/v823/rpt/108771.pdf
  4. ^ Peyman GA, Schulman JA, Sullivan B (1995). "Perfluorocarbon liquids in ophthalmology". Surv Ophthalmol. 39 (5): 375–95. PMID 7604361.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  5. ^ Chang S (1992). "Perfluorocarbon liquids in vitreoretinal surgery". Int Ophthalmol Clin. 32 (2): 153–63. PMID 1577557.
  6. ^ Rowson NJ, Bacon AS, Rosen PH (1992). "Perfluorocarbon heavy liquids in the management of posterior dislocation of the lens nucleus during phakoemulsification". Br J Ophthalmol. 76 (3): 169–70. PMC 504198. PMID 1540563. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  7. ^ Tewari A, Shah G (2006). "Management of Primary Retinal Detachments". Review Ophthalmol. News. 13 (04).
  8. ^ Yang YF, Herbert L, Rüschen H, Cooling RJ (2002). "Nitrous oxide anaesthesia in the presence of intraocular gas can cause irreversible blindness". BMJ. 325 (7363): 532–3. PMC 1124057. PMID 12217995. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  9. ^ Perfluorodecalin
  10. ^ Clark LC, Gollan F (1966). "Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure". Science (journal). 152 (730): 1755–6. PMID 5938414. Retrieved 2009-03-11. {{cite journal}}: Unknown parameter |month= ignored (help)
  11. ^ Clark
  12. ^ Race for Artificial Blood Heats Up - New York Times
  13. ^ "Perfluorochemucal Blood Substitutes", Naito, R., Yokoyama, K., p 57, The Green Cross Corporation, Technical Information Ser. No. 5, June 30, 1978
  14. ^ Perfluorocarbon compounds used as oxygen carriers. https://bdigital.ufp.pt/dspace/bitstream/10284/368/1/perfluorocarbons.pdf
  15. ^ Spahn DR (1999). "Blood substitutes. Artificial oxygen carriers: perfluorocarbon emulsions". Crit Care. 3 (5): R93–7. PMC 137239. PMID 11094488.
  16. ^ Zhu J, Hullett JB, Somera L; et al. (2007). "Intravenous perfluorocarbon emulsion increases nitrogen washout after venous gas emboli in rabbits". Undersea Hyperb Med. 34 (1): 7–20. PMID 17393935. Retrieved 2008-05-06. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  17. ^ Lundgren C, Bergoe G, Olszowka A, Tyssebotn I (2005). "Tissue nitrogen elimination in oxygen-breathing pigs is enhanced by fluorocarbon-derived intravascular micro-bubbles". Undersea Hyperb Med. 32 (4): 215–26. PMID 16238071. Retrieved 2008-05-06.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  18. ^ Spiess BD, McCarthy RJ, Tuman KJ, Woronowicz AW, Tool KA, Ivankovich AD (1988). "Treatment of decompression sickness with a perfluorocarbon emulsion (FC-43)". Undersea Biomed Res. 15 (1): 31–7. PMID 3368993. Retrieved 2008-05-06. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  19. ^ Dainer H, Nelson J, Brass K, Montcalm-Smith E, Mahon R (2007). "Short oxygen prebreathing and intravenous perfluorocarbon emulsion reduces morbidity and mortality in a swine saturation model of decompression sickness". J. Appl. Physiol. 102 (3): 1099–104. doi:10.1152/japplphysiol.01539.2005. PMID 17095628. Retrieved 2008-05-06. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  20. ^ Mahon RT, Dainer HM, Nelson JW (2006). "Decompression sickness in a swine model: isobaric denitrogenation and perfluorocarbon at depth". Aviat Space Environ Med. 77 (1): 8–12. PMID 16422447. Retrieved 2008-05-06. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  21. ^ Dromsky DM, Spiess BD, Fahlman A (2004). "Treatment of Decompression Sickness in Swine With Intravenous Perfluorocarbon Emulsion". US Naval Medical Research Center Technical Report. ADA453820. Retrieved 2008-05-06.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  22. ^ Lynch PR, Krasner LJ, Vinciquerra T, Shaffer TH (1989). "Effects of intravenous perfluorocarbon and oxygen breathing on acute decompression sickness in the hamster". Undersea Biomed Res. 16 (4): 275–81. PMID 2773159. Retrieved 2008-05-06. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  23. ^ Moon, R.E. (2000). "Adjunctive therapy in decompression illness: present and future". South Pacific Underwater Medicine Society journal. 30 (2). ISSN 0813-1988. OCLC 16986801. Retrieved 2008-05-06.
  24. ^ Electric & Electronic Applications
  25. ^ Stanzl K, Zastrow L, Röding J, Artmann C (1996). "The effectiveness of molecular oxygen in cosmetic formulations". Int J Cosmet Sci. 18 (3): 137–50. doi:10.1111/j.1467-2494.1996.tb00143.x. PMID 19245463. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  26. ^ http://www.research.ibm.com/journal/rd/362/ibmrd3602C.pdf
  27. ^ Fluorous Biphase Catalysis
  28. ^ a b Aslam M, Khalil K, Rasmussen RA; et al. (2003). "Atmospheric perfluorocarbons". Environ. Sci. Technol. 37 (19): 4358–61. PMID 14572085. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  29. ^ US EPA - High GWP Gases: Science
  30. ^ National Inventory Report: Information on Greenhouse Gas Sources and Sinks in Canada, 1990-2005
  31. ^ http://www.natural-resources.org/minerals/cd/docs/twb/PPAH/47_alum.pdf